Global Health Leadership Forum
University of California Berkeley and Barcelona Speakers
An International Program to Rethink
Health Policy and Health Systems Change
University of California's distinguished faculty is engaged in advanced research and is in constant dialogue with executives who are leading their industries. These activities ensure that you are immersed in the most critical and contemporary issues. Through this interaction, you'll learn to recognize the types of information and intuition that stimulate effective implementation of health care strategy and vision in organizations and countries. We are grateful to our guest speakers, well-known health care leaders who have agreed to join us in our quest to advance the state of knowledge regarding effective health care policies and management.
Berkeley 2010 Speakers
Peter Berman, Ph.D.
- Lead Health Economist, World Bank's HNP anchor department
- Adjunct Professor of Population and International Health at Harvard School of Public Health
Prof. Peter Berman (M.Sc, Ph.D) is a health economist with thirty years of experience in research, policy analysis and development, and training and education in global health. In July 2008 he became Lead Health Economist in the World Bank's HNP anchor department after completing a four year assignment in the World Bank's New Delhi office as Lead Economist for Health,Nutrition, and Population. He is also Adjunct Professor of Population and International Health at Harvard School of Public Health. Previously at Harvard he was Professor of Population and International Health Economics and Director of the International Health Systems Program (IHSP, see www.hsph.harvard.edu/ihsg/ihsg.html) in the Population and International Health Department. Prof. Berman is the author or editor of five books on global health economics and policy as well as dozens of academic articles and papers. He has led and/or participated in major field programs in all regions of the developing world.
Prof. Berman's specific areas of technical expertise include analysis of health systems performance and the design of reform strategies; assessment of the supply side of health care delivery and the role of private health care provision in health systems and development of strategies to improve outcomes through public-private sector collaboration; and the use of national health accounts as a policy and planning tool. Prof. Berman has worked extensively on health system reform issues in a number of countries, including Egypt, India, Colombia, Indonesia, and Poland. He is co-author of Getting Health Reform Right: A Guide to Improving Performance and Equity (Roberts, et al, Oxford University Press, 2003), co-editor of the recently published Guide to the Production of National Health Accounts (World Bank, World Health Organization, and USAID, 2003), and co-editor of Paying for India's Health Care (Sage, 1993).
Simone Buitendijk, M.D., M.P.H., Ph.D.
- Professor of Integrative Preventive Care of Children
- Head, Child Health Program, TNO Quality of Life
Sir Richard G. A. Feachem, K.B.E., B.Sc., F.R.Eng., Ph.D., D.Sc. (Med), F.I.C.
- First Executive Director, Global Fund to Fight AIDS, Tuberculosis and Malaria
- Undersecretary General, United Nations
- Professor of International Health, University of California, San Francisco and the University of California, Berkeley
- Founding Director, Institute for Global Health, UCSF and UCB
http://www.theglobalfund.org
Dr. Richard Feachem has worked in international health and development for 30 years and has published extensively on public health and health policy.
Dr. Feachem stepped down as the first Executive Director for the Global Fund to Fight AIDS, Tuberculosis and Malaria on March 31, 2007 after a five year term. Prior to his position at the Global Fund, Dr. Feachem was Director for Health, Nutrition and Population at the World Bank and Dean of the London School of Hygiene and Tropical Medicine.
Sir Richard was knighted by Her Majesty Queen Elizabeth II in 2007. He has also received honours from the Governments of Niger and Togo.
Neelam Sekhri Feachem, M.H.A.
- Chief Executive Officer, The Healthcare Redesign Group
As founder of The Healthcare Redesign Group Inc. in 1994, Ms. Sekhri Feachem heads a consultancy that has been recognized by the San Francisco Business Times as one of the fastest-growing privately-held companies in the San Francisco area. She advises government ministries, insurers, providers and international organizations on a health systems, health financing and health policy issues.
Prior to founding The Healthcare Redesign Group, Ms. Sekhri Feachem spent 14 years with Kaiser Permanente where she held executive positions in hospital and medical group management, organizational development, and finance.
Ms. Sekhri Feachem has served on various Boards including the Commercial Advisory Board of the British National Health Service, the Organization for Economic Development (OECD) Working Group for Private Insurance and the Board of the Alameda County Hospital system.
George C. Halvorson
- Chairman and Chief Executive Officer, Kaiser Foundation Health Plan/Hospitals
Dean Jamison, Ph.D.
- Professor of Global Health, School of Public Health, University of Washington
Donald W. Kemper, M.P.H.
- Chairman and CEO, Healthwise, a not-for-profit organization dedicated to helping people make better health decisions
- Founding Chair, IxCenter Board of Directors
Mr. Kemper co-authored Information Therapy: Prescribed Information as a Reimbursable Medical Service with Molly Mettler. The Ix® book lays out both the concept and the practical details of how information prescriptions will become a core and expected part of health care.
Hal Luft, Ph.D.
- Director, Palo Alto Medical Foundation Research Institute
- Caldwell B. Esselstyn Professor Emeritus of Health Policy and Health Economics
Philip R. Lee Institute for Health Policy Studies
University of California San Francisco
Arnold Milstein, M.D.
- Medical Director, Pacific Business Group on Health (PBGH)
- National Health Care Thought Leader, William H. Mercer
Ian Morrison, M.A., Ph.D.
- Senior Research Fellow and President Emeritus, Institute for the Future (IFTF)
- Health Advisory Panel Chair, Institute for the Future's Health Advisory Panel
- Founding Partner, Strategic Health Perspectives (SHP)
Robert Pearl, M.D.
- Chief Executive Officer, The Permanente Medical Group
Dr. Robert Pearl is responsible for the health care of more than 3.1 million Kaiser Permanente Northern California members. The Permanente Medical Group is composed of approximately 4,400 physicians and 20,000 staff members.
Over the past decade, Dr. Pearl has been a leader in implementing advanced information technology systems across Kaiser Permanente. By combining an integrated delivery system with Internet technology he believes that Kaiser Permanente is uniquely positioned to redefine the practice of medicine as we know it today and develop the health care solutions for the 21st century.
Dr. Robert Pearl received his MD from Yale University School of Medicine. He completed his residency in Plastic and Reconstructive Surgery at Stanford University where he has been a faculty member since 1978. Dr. Pearl has published more than 100 articles in various medical journals, has been a contributor to many books, and has served as a visiting professor at Stanford Business School, Duke University School of Medicine, and Harvard School of Public Health.
Molly Porter
- Training Director, Kaiser Permanente International
Responsibilities:
- develop and implement educational programs about Kaiser Permanente for international visitors.
- Makes presentations about Kaiser Permanente at international conferences and to international groups visiting California. Countries visited on business in the past year include Brazil, the United Kingdom, the Netherlands, Germany, and Denmark
Alexander S. Preker, M.D., Ph.D.
- Lead Economist for Health, Nutrition and Population for West Africa, World Bank: US$1.8 billion under active implementation and US$164 million in the pipeline
- Editor, World Bank's HNP Publication Series
James A. Rice, Ph.D.
- President, International Health Summit
- Vice-Chairman, Governance Institute
- Consultant, Larson Allen
Dr. Rice's 30 years of experience also includes important work as a teacher, author, speaker and consultant to physician groups, boards of directors and health sector leaders in over 30 countries. He also works in international health policy research and development, with a special focus on public health finance. He has received many distinguished awards, including the Corning Award for excellence in U.S. hospital planning. He is the co-founder and former president of the AHA Society for Hospital Planning and Marketing.
Mark Smith, M.D., M.B.A.
- President and CEO of California HealthCare Foundation
Dr. Mark Smith is president and chief executive officer of the California HealthCare Foundation. The Foundation is an independent philanthropy with assets of more than $900 million, headquartered in Oakland, California, and dedicated to improving the health of the people of California through its three program areas: Better Chronic Disease Care, Innovations for the Underserved, and Market and Policy Monitor.
A board-certified internist, Smith is a member of the clinical faculty at the University of California, San Francisco, and an attending physician at the Positive Health Program for AIDS care at San Francisco General Hospital. He is a member of the Institute of Medicine and serves on the board of the National Business Group on Health.
Prior to joining the California HealthCare Foundation, Smith was executive vice president at the Henry J. Kaiser Family Foundation. He previously served as associate director of the AIDS Services and assistant professor of medicine and of health policy and management at Johns Hopkins University. He has served on the Performance Measurement Committee of the National Committee for Quality Assurance and the editorial board of the Annals of Internal Medicine.
Smith received a bachelor's degree in Afro-American studies from Harvard College, a medical doctorate from the University of North Carolina at Chapel Hill, and a master's in business, with a concentration in health care administration, from the Wharton School at the University of Pennsylvania.
Paul Wallace, M.D.
- Medical Director for Health and Productivity Management Programs Kaiser Permanente
Paul Wallace, MD, has combined experiences in clinical medical oncology and hematology practice with work in quality improvement, especially in the areas of performance measurement, evidence based medicine and population based care. As in Kaiser Permanente’s national Permanente Federation, he has responsibilities for the development and analysis of clinical population-based wellness and health maintenance interventions.
Andrew M. Wiesenthal, M.D., S.M.
Andrew M. Wiesenthal, MD, SM is Associate Executive Director of the Permanente Federation for Clinical Information Support. From 1983 until April 2000, Dr. Wiesenthal served as a pediatrician and pediatric infectious disease consultant with the Colorado Permanente Medical Group (CPMG). He also led CPMG's quality management program and served as Associate Medical Director for Medical Management, with responsibility for quality management, utilization management, regulatory compliance, risk management, credentialing and physician performance, and informatics. His current work is in the arenas of development and deployment of automated medical records, decision support, and other clinical systems for all of Kaiser Permanente.
Dr. Wiesenthal graduated from Yale University with a BA degree with honors in Latin American Studies in 1971 and received his MD in 1975 from the State University of New York, Downstate Medical Center in Brooklyn. He completed his pediatric residency at the University of Colorado in 1978 and then served as an Epidemic Intelligence Service Officer with the Centers for Disease Control from 1978-80 before returning to the University of Colorado for a pediatric infectious disease fellowship, which was completed in 1983. In 2004, Dr. Wiesenthal earned an SM in Health Care Management from the Harvard School of Public Health.
FACULTY:
Jennifer Chatman, Ph.D.
- Director, Haas School, Ph.D. Program, UC Berkeley
- Paul J. Cortese Distinguished Professor of Management
- Haas Organizational Behavior and Industrial Relations Group
Jodi Halpern, M.D., Ph.D.
- Associate Professor of Bioethics, Joint Medical Program, School of Public Health, UC Berkeley
Teh-wei Hu, Ph.D.
- Professor Emeritus, School of Public Health, UC Berkeley
Meg A. Kellogg
- Health Care Consultant
- Program Director, Global Health Leadership Forum, School of Public Health, UC Berkeley
Guillem López-Casasnovas, Ph.D.
- Faculty Advisor, Global Health Leadership Forum
- Board of Directors, Bank of Spain
- Professor of Applied Economics, Department of Economics and Business, Universitat Pompeu Fabra
- IHEA 2009 President; previously IHEA 2005 Conference Chair
Location: Jaume I Building (Campus de la Ciutadella), C/ Ramón Trias Fargas 25-27, 08005 Barcelona
Web site: Guillem López-Casasnovas
Guillem López-Casasnovas is a distinguished member of the Royal College of Economists of Catalonia, a Member of the Royal Academy of Medicine of Catalonia and is associated with the Spanish Academy. As a member of the Advisory Council of the Spanish Ministry of Health and the Catalan Health Department, he has served on commissions on Health Policy, Pharmaceuticals, Health System Reform, Hospital Financing, Ageing and Social Security, and Long Term Care.
He chaired the International Health Economics Association (iHEA) 2005 Conference. In March 2005 he was appointed to the Board of Directors of the Bank of Spain.
Thomas Rundall, Ph.D.
- Executive Associate Dean, School of Public Health, UC Berkeley
- Henry J. Kaiser Professor of Organized Health Systems
Faculty Web Page: Professor Rundall
William Satariano, Ph.D., M.P.H.
- Professor of Epidemiology and Community Health, School of Public Health, UC Berkeley
Richard Scheffler, Ph.D.
- Faculty Advisor, Global Health Leadership Forum
- Distinguished Professor of Health Economics & Public Policy/Director, Petris Center
Global Health Leadership Forum
Goldman School of Public Policy - Faculty Page
Health Policy Training Programs at SPH
Petris Center on Healthcare Markets & Consumer Welfare
Stephen Shortell, Ph.D.
- Dean, School of Public Health, UC Berkeley
- Blue Cross of California, Distinguished Professor of Health Policy & Management
Website: National Study of Physician Organizations
Berkeley Past Guest Speakers
Bruce Bodaken
- President, Chairman, and CEO, Blue Shield of California
Dov Chernichovsky, M.A., Ph.D.
- Lecturer and Professor of Health Sciences, Department of Health Policy and Management, Ben-Gurion University of the Negev, Israel
- Research Associate, National Bureau of Economic Research, NYC
- Consultant, World Bank, Washington DC
- Visiting Senior Lecturer, Bar-Ilan University, Israel
Dr. Dov Chernichovsky is the health system adviser to the Israeli Parliament, heads the Health Team at the Taub Centre for Social Policy Studies in Israel, and is a Research Associate with the National Bureau of Economic Research (NBER).
Molly Joel Coye, M.D., M.P.H.
- Founder and CEO, Health Technology Center (HealthTech)
Dr. Coye was an executive in the Good Samaritan Health System, a large nonprofit integrated health care system in California, and she also directed product development and marketing for HealthDesk Corporation, a developer of consumer software for interactive health communication and disease management. From 1991 to 1993, Dr. Coye was the director of the California Department of Health Services, managing a budget of more than $16 billion, 5,000 employees and 160 branch and field offices throughout the state.
Fluent in Spanish and Chinese, she has also served as a consultant with the World Health Organization and the Pan American Health Organization.
Susan Desmond-Hellmann, M.D., M.P.H.
- President, Product Development, Genentech
- Adjunct Associate Professor, Epidemiology and Biostatistics, University of California, San Francisco
Dr. Susan Desmond-Hellmann is responsible for Genentech's Development, Regulatory Affairs, Quality, Compliance, Product Portfolio Management, Alliance Management, Business Development and Pipeline Strategy Support functions. Dr. Hellmann is a member of Genentech's executive committee.
Dr. Hellmann joined Genentech in 1995 as a clinical scientist and she was named executive vice president, Development and Product Operations in 1999, and chief medical officer in 1996. Hellmann is board-certified in Internal Medicine and Medical Oncology and completed her clinical training at UCSF. Prior to joining Genentech, Hellmann was associate director of clinical cancer research at Bristol-Myers Squibb's Pharmaceutical Research Institute. While at Bristol-Myers Squibb, she was the project team leader for Taxol.
John Ellwood, Ph.D.
- Professor of Public Policy
Alain C. Enthoven, Ph.D.
- Marriner S. Eccles Professor of Public and Private Management, Emeritus, Graduate School of Business, Stanford University
- Senior Fellow, Center for Health Policy, Institute of International Relations, Stanford University
Harvey Fineberg, M.D., Ph.D.
- President, U.S. Institute of Medicine of The National Academies
- Professor Emeritus of Health Policy and Management, Department of Health Policy and Management
Pamela Garside, MHA
- Visiting faculty at Judge Business School, the business school of the University of Cambridge
- Co-Director of the Cambridge Programme of the Global Health Leadership Forum
- Owner of Newhealth, a management consultancy specialsing in organizational strategy and development in health care
Pam Garside has her own management consultancy, Newhealth, specialising in organisational strategy and development in health care. She is a member of the visiting faculty at Judge Business School, the business school of the University of Cambridge, where she is Co-Director of the Cambridge International Health Leadership Programme. She began her professional life in management in the NHS and subsequently spent ten years studying and working internationally based in the USA. Since the mid-1980s she has worked as a management adviser and consultant concentrating on the reform of healthcare systems, and leadership and management development.
Pam is a member of the board of Quality and Safety in Health Care, a BMJ publication, Chairman of the Board of Governors of the Royal College of Nursing's School of Higher Education, and a Board Director of the International Women's Forum Leadership Foundation in Washington DC. She is co-owner and Chairman of the International Health Summit, USA and a Senior Associate of the Nuffield Trust. She is also a member of the Organisational Analysis research group and the Human Resources & Organisations teaching group.
John Kitzhaber, M.D.
- Two-term Governor of Oregon, USA
Kenneth W. Kizer, M.D., M.P.H.
- President and CEO of National Quality Forum
David Lawrence, M.D.
- Former CEO and Chairman of Board, Kaiser Foundation Health Plan
Dr. Matthijs (Matt) Muijen, M.D.
- Regional Advisor for Mental Health, WHO, Europe
Philip Musgrove, Ph.D.
- Deputy Editor for Global Health, Health Affairs Journal
- Adjunct Professor of International Relations, Johns Hopkins University
From October 2002 to September 2005, Dr. Musgrove was an Editor of the Disease Control Priorities Project at the Fogarty International Center of the National Institutes of Health. He worked for the World Bank (1990-2002), retiring as a Principal Economist, having been Advisor in Health Economics, Pan American Health Organization (1982-1990) and a Research Associate at the Brookings Institution and at Resources for the Future (1964-1981).
Edward Penhoet, Ph.D.
- Professor of Health Policy & Management
- President, Gordon & Betty Moore Foundation
Kristiana Raube, Ph.D., M.P.H.
- Adjunct Professor and Executive Director, Graduate Program in Health Management
Murray Ross, Ph.D.
- Director, Health Policy Analysis and Research
- Kaiser Permanente Institute for Health Policy
- Kaiser Permanente Medical Care Program
James Robinson, Ph.D., M.P.H.
- Professor of Health Economics
Richard B. Saltman, Ph.D.
- Professor of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta, Georgia
- Associate Director, European Observatory
Richard B. Saltman is Professor of Health Policy and Management at the Emory University School of Public Health in Atlanta, Georgia. He is also Associate Director of Research Policy of the European Observatory on Health Care Systems, an international partnership based in Brussels. He is an Adjunct Professor of Political Science at Emory University, a Visiting Professor at the London School of Economics and Political Science, and Visiting Professor at the Braun School of Public Health at the Hebrew University in Jerusalem. From 1991 to 1994, he was Director of the Department of Health Policy and Management at Emory. Previously he was Associate Professor at the University of Massachusetts School of Public Health (1985 - 1991) and Research Associate in Political Science at Harvard School of Public Health (1980 - 1985). He holds a doctorate in political science from Stanford University.
Leonard D. Schaeffer
Leonard D. Schaeffer is the founding Chairman & CEO of WellPoint, the nation's largest health insurance company. WellPoint has over 34 million medical members and revenues of over $56 billion. He is currently Chairman of Surgical Care Affiliates and a Senior Advisor to TPG Capital, a private equity firm.
Mr. Schaeffer was Chairman & CEO of WellPoint from 1993 through 2004 and continued as Chairman through 2005. In 1986, Mr. Schaeffer was recruited as CEO of WellPoint's predecessor company, Blue Cross of California, when it was near bankruptcy. He managed the turnaround of Blue Cross, founded WellPoint and completed 17 acquisitions. During his tenure, the company grew in value from $11 million to over $49 billion. Under Mr. Schaeffer's leadership, WellPoint was selected by Fortune as America's Most Admired Health Care Company for six consecutive years and by BusinessWeek as one of the 50 best performing public companies for three consecutive years. Mr. Schaeffer was selected by BusinessWeek as one of the Top 25 Managers of the Year and by Worth as one of the "50 Best CEOs in America".
Mr. Schaeffer's public service included appointments as Administrator of the federal Health Care Financing Administration (now CMS), Assistant Secretary for Management and Budget of the federal Department of Health, Education and Welfare, Director of the Bureau of the Budget for the state of Illinois, Chairman of the Illinois Capital Development Board, and Deputy Director of the Illinois Department of Mental Health.
Mr. Schaeffer was also President & CEO of Group Health, Inc., EVP & COO of the Student Loan Marketing Association, (Sallie Mae) and a Vice President of Citibank.
Onno Schellekens, M.B.A.
Managing Director, PharmAccess
The Netherlands
PharmAccess Foundation is a Dutch not-for-profit organization supporting basic health care including HIV/AIDS treatment and care in Africa. Onno Schellekens is responsible for the day-to-day practices of the organization.
Mr. Schellekens is founder of the Health Insurance Fund and the Investment Fund for Health in Africa. The Health Insurance Fund (HIF), established in 2005, aims to introduce medical insurance schemes for low- and no-income groups through private healthcare providers. In 2006 the HIF received a grant of 100 million Euro from the Dutch government. In 2006 the HIF launched its first program in Nigeria. He also initiated the Investment Fund for Health in Africa in 2007 which was launched with support of three large banks and insurers, SNS Reaal, ACHMEA and AEGON. They provide investment capital for the fund.
Joanne Spetz, Ph.D.
- Associate Director, Center for Health Workforce Studies
- Assistant Adjunct Professor, Community Health Systems, School of Nursing
Web site: Faculty Profile
2009 Barcelona Faculty and Guest Speakers
Ronald Leslie Akehurst
- Dean and Professor of Health Economics, School of Health and Related Research (ScHARR), The University of Sheffield, United Kingdom
Ron Akehurst is Dean of ScHARR, a major centre for Health Services Research in Europe with some 200 staff, and is Professor of Health Economics. His interests are primarily in Health Technology Assessment (HTA) and he has published widely in that area. He has had some involvement in developing HTA processes in other countries, including Hungary, Korea and Australia.
Dr. Akehurst was a founding member of the National Institute for Clinical Excellence (NICE) Appraisal Committee, serving on it for 7 years; served on the NICE Topic Selection Committee; the NICE Public Health Interventions Advisory Committee and still serves on the NICE Methodology Committee. ScHARR is the largest supplier of analytic services to NICE (Assessment Reports; Evidence Reviews; Guideline Development; Interventional Procedures; Decision Support).
Past activities include a 2 year period as an Economic Advisor to the Department of Health and as a Specialist Advisor to the Parliamentary House of Commons Health Select Committee for 3 years. Dr. Akehurst spent 3 years as a Non-Executive Director of a Health Authority, responsible for commissioning Health Services.
Since the mid 1980s Dr. Akehurst has been involved with working with pharmaceutical and devices industries to evaluate the cost-effectiveness of their products. He has been involved in many submissions on behalf of companies to NICE, SMC, AWMSG, PBAC and occasionally to other bodies such as IFN and in the production of global dossiers. He has helped set up HEOR departments within drug companies and to train their staff. More recently he has been involved in helping companies re-engineer their internal processes to move drugs from discovery to market.
John Appleby
- Chief Economist, The King's Fund
- Visiting Professor, City University
John Appleby (http://www.kingsfund.org.uk/who_we_are/whos_who/john_appleby.html) joined the King's Fund in December 1998 following senior lectureships in health economics at the Universities of East Anglia and Birmingham. After his masters in health economics at the University of York in 1980, he worked in the NHS for seven years in Birmingham and London. For five years he worked for the National Association of Health Authorities (now the NHS Confederation) as manager of the Association's Central Policy Unit.
The focus of his research and commentary work at the King's Fund is on current health policy matters, in particular the economic issues associated with the government's reform agenda for health care such as the introduction of competitive forces into the NHS, the use of targets to reduce waiting times, patient choice, payment by results and patient reported outcome measures. Prof Appleby has published widely on a range of health care finance and economic issues in books, academic journals, reports, magazines and newspapers. Recent research include a major study of NHS performance since 2002 with Sir Derek Wanless, published by the King's Fund (http://www.kingsfund.org.uk/research/publications/our_future.html); an analysis of the the public's attitudes to the NHS (25th British Social Attitudes survey, http://www.natcen.ac.uk/bsa/);and future policy directions for the English health system (Options for a New Britain http://www.palgrave.com/products/title.aspx?PID=333476 )
As well as his post at the King's Fund, John is a Visiting Professor at the Department of Economics, City University where he teaches and carries out joint research with colleagues in the City Health Economics Centre (http://www.city.ac.uk/economics/research/chec/ )
John has also acted as an advisor to the UK government and Parliament in various capacities, for example, carrying out a review for Ministers of the future funding needs of Northern Ireland's health service (http://www.dhsspsni.gov.uk/show_publications?txtid=13662),
and currently, as a task force member for the Marmot Commission on health inequalities; a special adviser to the House of Commons Health Select Committee and as a health economics expert for the Prime Minister's Commission on the Future of Nursing and Midwifery.
Boris Azais
- Director of European Government Affairs at Merck, Sharp & Dohme.
Boris Azais is Director of European Government Affairs at Merck, Sharp & Dohme, a subsidiary of the pharmaceutical company Merck & Co. His work focuses on pharmaceutical policy, both in its industrial and public heatlth components. Boris Azais trained as a lawyer and early in his career practiced law in Paris. In 1998, he joined Merck Sharp & Dohme to work in the Middle East & Africa region where he was in charge of Legal Affairs. While working for Merck Sharp & Dohme, Boris Azais supported several leading partnership initiatives in the field of access to medicines in Africa, including the Accelerating Access Initiative, an initiative launched in 2001 that triggered a significant increase in the availability of antiretrovial treatment for HIV in more than 100 countries. In 2003, he was seconded to the International Federation of Pharmaceutical Manufacturers and Associations in Geneva, where he worked as Director of External Policy. His activities included interacting with the United Nations agencies, such as the World Health Organization on partnership programs and pharmaceutical policy. Boris Azais is the author of several articles on pharmaceutical innovation, Research & Development for neglected tropical diseases and international competitiveness.
Rafael Bengoa, M.D.
- Director, Health System Policies and Operations, World Health Organization (WHO), Geneva, Swtizerland
Dr. Rafael Bengoa has worked as a staff member for WHO at several levels and as a consultant for the World Bank. Until recently he was Director of the Department of Management of Noncommunicable Diseases. Before joining WHO, Dr Bengoa was responsible for running health services in the Basque Country Region of Spain and has been responsible for producing several policy reports on health care reform and public health to the Spanish Parliament. His main technical interest is connecting medicine and public health agendas.
Josep Figueras, MD, MPH, PhD
- Director of the European Observatory on Health Systems and Policies and head of the WHO European Centre on Health Policy in Brussels
Josep Figueras, MD, MPH, PhD (econ) is the Director of the European Observatory on Health Systems and Policies and head of the WHO European Centre on Health Policy in Brussels. In addition to WHO, he has worked in collaboration with all major multilateral organizations such as the European Commission or the World Bank. He is member of several advisory and editorial boards and has served as advisor in more than thirty countries within the European region and beyond. He is honorary fellow of the UK faculty of public health medicine, has been awarded twice the EHMA price for the best annual publication on policy and management, and in 2006 he was awarded the Andrija Stampar Medal. He has been lecturer and head of the MSc in Health Services Management at the London School of Hygiene & Tropical Medicine.
His research focuses on comparative health system and policy analysis. He is editor of the European Observatory series published by Open University Press and has published several volumes in the field of health systems analysis including Health systems, health and wealth (2009), Impact of EU mobility (2009), Health Impact Assessment (2007), Purchasing to improve performance (2005), Health Systems in Transition (2004) Social health insurance (2004) Funding health care (2002) Critical challenges for European reform (1998) and European Health Care Reform: analysis of strategies (1997).
Pere Ibern, M.B.A., Ph.D.
- Associate Professor of Business, Department of Economics and Business, Universitat Pompeu Fabra
- President, Associacion de Economia de la Salud (Spanish Health Economics Association)
- Strategic Development Director, DKV Seguros (insurance company)
Location: Jaume I Building (Campus de la Ciutadella), C/ Ramón Trias Fargas 25-27, 08005 Barcelona
Website: http://www.econ.upf.es/~ibern/
Dr. Pere Ibern has taught health economics and health policy and also has held executive positions in health care organizations. His research activity has been focused on the application of the economics of organization and regulation to the health care sector. He was also Visiting Researcher of the Center for Demographic Studies at Duke University. He has been a consultant for the Human Development Department of The World Bank and has presented testimony to the Spanish Parliamentary Commission on Health Reform.
Mireia Jofre
- A reader in Economics at the Department of Economics of City University, London, UK
- a Senior Associated Researcher at LSE Health and Social Policy
Mireia Jofre-Bonet is a Reader in Economics at the Department of Economics of City University, London, UK. She is a Senior Associated Researcher at LSE Health and Social Policy and also collaborates with the London School of Hygiene and Tropical Medicine - and the Moorfields Trust to evaluate interventions aimed at fighting blindness in developing countries and the UK. Prior to joining City University in January 2006, Ms. Jofre had been a Lecturer at LSHTM, a Research Faculty member at the School of Public Health of Yale University, and had taught at the Departments of Economics of the London School of Economics and of Yale University. Mireia has contributed to health economics projects and reviews for private and public institutions - including the UK Department of Health, the NIHR Health Technology Assessment programme, and the Catalan and the Balearic Island's Departments of Health.
Fields of interest: Health production functions and Lifestyle decisions; Impact of Substance Abuse and Mental Health on productivity. Economic Evaluation applied to Substance Abuse and to Eye Disease. Demand of Health Insurance and topics of Industrial Organization applied to the demand for Health Care.
Panos Kanavos
-
Senior Lecturer in International Health Policy in the Department of Social Policy and Head, Medical Technology Research Unit, London School of Economics and Political Science, UK
Panos Kanavos is Senior Lecturer in International Health Policy in the Department of Social Policy and Head of the Medical Technology Research Unit at LSE Health. He is also Visiting Professor at the University of Lausanne. He has acted as advisor to a number of international governmental and non-governmental organisations, including the World Bank, the World Health Organisation and the Organisation for Economic Co-operation and Development, the American Association for Retired Persons and Ministries of Health in over 21 transition and developing countries. He is currently participating in the European Pharmaceutical Forum as advisor to the European Commission. His research interests comprise comparative health policy and health care reform; pharmaceutical economics and policy; quality in health care; and the socio-economic determinants of health.
Marc le Menestrel
- Associate Professor, Universitat Pompeu Fabra (Barcelona)
- Visiting Professor of Ethics, INSEAD (Fontainebleau and Singapore)
Dr. le Menestrel teaches business at University Pompeu Fabra (Barcelona) where he is Associate Professor and at INSEAD (Fontainebleau and Singapore) where he is Visiting Professor of ethics. His core expertise is in decision making, in particular the role of ethical values in business decisions. He proposes frameworks to improve decision-making in the presence of dilemmas between economic, environmental, social and individual values.
At the practical level, Dr. le Menestrel has worked and taught about ethical rationality, value-based strategic management, responsible leadership, communication in ethical crisis, corporate social responsibility, codes of conduct or e-business ethics. At the theoretical level, Marc does research on the rationality of human behaviour. Studying the mathematical foundations of the theory of choice, he uses objective and experimental methods to better reveal the subjectivity of human behaviour.
His work has appeared in publications such as The Journal of Mathematical Psychology, Theory and Decision, Discrete Mathematics, The European Journal of Operational Research, The Journal of Economics and Business Organizations, The Journal of Business Ethics, Business Ethics: A European Review.
Dr. le Menestrel holds a Ph.D. from INSEAD in Decision Sciences (1999). He has graduated from the Paris Graduate Management School (ESCP) in 1991 and has a two-year undergraduate degree in mathematics from University Paris VI (1986).
In 2008, Dr. le Menestrel has created the "Dreaming in Business" sessions, taught in particular to Senior Executives at INSEAD. Linking analytical and emotional intelligence in a manner that delivers practical insights, this new and audacious approach has received a strong support from decision-makers. He is the Founder of the Foundation for a New Ethical Business, an open institution aimed at researching, teaching and promoting new ways of doing business at the service of human values, social justice and environmental sustainability: www.newethicalbusiness.org.
Felix Lobo
- Professor, Applied Economics, universities of Santiago de Compostela, Oviedo and Carlos III de Madrid (1990-2005; 2008-)
- Director, Seminar of Social Studies on Health and Medicines, Universidad Carlos III de Madrid.
- Temporary officer and consultant to international organizations: UNIDO, WHO, PAHO, World Bank, European Union and various firms
Public Service : General Director for Pharmaceuticals and Medical Devices, Ministry of Health and Consumers Affairs, Spain (Dec.1982-April 1988); Vice-Chancellor for economic affairs, Universidad Internacional Menendez Pelayo, Santander and Madrid (1989-1990); Vice-Chancellor for postgraduate studies, Universidad Carlos III de Madrid (1995- 1999); Dean, Faculty of Social Sciences and Law, Universidad Carlos III de Madrid (2004-2005). President, Spanish Food Safety and Nutrition Agency (2005-2008).
Recent Publications: Medicines and the New Economic Environment, 1998, (editor with G. Velasquez), Civitas and WHO, Madrid; "Implementing R&D Policies: An Analysis of Spain's Pharmaceutical Research Program", with K. Desmet and P. Kujal, Research Policy, Vol. 33, 2004, p. 1493-1507; "Direct Healthcare Costs of Diabetes Mellitus Patients In Spain", with J. Oliva, B. Molina and S. Monereo, Diabetes Care, Vol 27 N. 11, November 2004, p. 2626-2621; "Costes no sanitarios ocasionados por las enfermedades isquemicas del corazon en Espana" with J. Oliva, J. Lopez Bastidas, B. Duque and R. Osuna, Cuadernos Economicos ICE, N. 67, 2004, p. 263-298; "Indirect Costs of Cervical and Breast Cancer in Spain", with J. Oliva, J. Lopez Bastidas., N. Zozaya y R. Romay, The European Journal of Health Economics, Vol. 6, N. 4, December 2005, p.309-313.
Dr. Lobo is a member, World Health Organization Expert Advisory Panel on Drug Policies and Management. He received his Degree in Law (1968), and his Ph.D. in Economics, University of Madrid (1977).
Guillem López-Casasnovas, Ph.D.
- Faculty Advisor, Global Health Leadership Forum
- Board of Directors, Bank of Spain
- Professor of Applied Economics, Department of Economics and Business, Universitat Pompeu Fabra
Location: Jaume I Building (Campus de la Ciutadella), C/ Ramón Trias Fargas 25-27, 08005 Barcelona
Web site: Guillem López-Casasnovas
Guillem López-Casasnovas is a distinguished member of the Royal College of Economists of Catalonia, a Member of the Royal Academy of Medicine of Catalonia and is associated with the Spanish Academy. As a member of the Advisory Council of the Spanish Ministry of Health and the Catalan Health Department, he has served on commissions on Health Policy, Pharmaceuticals, Health System Reform, Hospital Financing, Ageing and Social Security, and Long Term Care.
He chaired the International Health Economics Association (iHEA) 2005 Conference. In March 2005 he was appointed to the Board of Directors of the Bank of Spain.
Nùria Mas, M.A., Ph.D.
- Assistant Professor of Economics, IESE Business School, Universidad de Navarra
Location: C/ Taquígraf Garriga 95, Barcelona, 08029
Website: http://wwwapp.iese.edu/faculty/
Nuria Mas is an Assistant Professor of Economics at IESE Business School, where she teaches the "Markets and Managers" course in the MBA and the "Microeconomics" course in the Doctoral program. Before joining IESE Business School, Prof. Mas worked as an Associate at Lehman Brothers International.
Prof. Mas recieved a Ph.D. in Economics from Harvard University and a B.A. in Economics from Universitat Pompeu Fabra, Barcelona.
Dr. Mas' research interests focus on the interaction between the public and the private sector, with an emphasis on the health care market. She also analyzes how hospitals and doctors respond to different incentive mechanisms. For example, she studies how different types of health insurance programs affect the incentives of hospitals to adopt new technologies or to provide health care to the uninsured. She also has several projects assessing the effect of different health care systems on the health of their population.
Vicente Ortún, M.Sc., Ph.D.
- Faculty Coordinator, Advanced Health Leadership Forum
- Senior Lecturer of Economics and Business
- Director of CRES
- President of Spanish Health Economics Association
Location: Jaume I, 291, C/ Ramón Trias Fargas 25-27, 08005 Barcelona
Website: http://www.econ.upf.es/~ortun/
Jaume Puig
- Co-director of the Research Center for Economy and Health (CRES), UPF, since 2006.
- Associate Professor, Department of Economics and Business, Universitat Pompeu Fabra, since 1992.
Jaume Puig served the Autonomous Government of Catalonia as Head of the Information Division of the Catalan Health Service (1989-1992). He also was Head of the Social Security Budget Office of the Health and Social Security Department, Autonomous Government of Catalonia (1988-1989). He also worked at the Government as Economist in different staff positions in the Health and Social Security Department during previous years (1983-1988).
Doctor of Philosophy (PhD.) Economics and Business Faculty from the Autonomous University of Barcelona, he has done several research papers such as "Economic evaluations of massive HPV vaccination: Within-study and between study variations in incremental cost per QALY gained (with B. Gonzalez), Preventive Medicine 2009, online first".
He is also Director of the Health Economics and Pharmacoeconomics International Master's Degree (UPF).
Marisol Rodríguez, M.Sc., Ph.D.
- Senior Lecturer in Economics, University of Barcelona
- Deputy Director, Welfare Economics Research Center, Centre de Recerca en Economia del Benestar (CREB)
Location: Parc Científic de Barcelona, Torre D, C/ Baldiri Reixac, 4-6, 3 Floor, B2 08028 Barcelona
Website: http://riscd2.eco.ub.es/~creb/members/marisol.html
Bernard van den Berg,
- Assistant professor in health economics, VU University Amsterdam
- Visiting professor Faculty of Economic and Business Sciences & CRES, Universitat Pompeu Fabra, Barcelona, Spain
Bernard van den Berg is assistant professor in health economics, VU University Amsterdam, The Netherlands. He has a Ph.D. from Erasmus University Rotterdam, The Netherlands. After his Ph.D. he was a post-doctoral fellow on project "Evaluating health policy by understanding consumer and provider decisions about health care: a micro-econometric approach", Centre for Health Economics and Evaluation, Faculty of Business, University of Technology, Sydney, Australia.
Main research topics include economic aspects of long-term care and informal care. Managed competition in health care and measuring quality of care from an economic perspective. Use of stated preference methods like conjoint analysis (discrete choice experiments), contingent valuation, and the well-being valuation method in health economics.
Barcelona Past Guest Speakers
Oriol Amat, M.B.A., Ph.D.
- Professor and Vice-Rector, Department of Economics and Business, Universitat Pompeu Fabra
- Director of the Master in Accounting and Financial Management, Continuing Education Institute (iDEC), Universitat Pompeu Fabra
Location: Jaume I, 208, C/ Ramón Trias Fargas 25-27, 08005 Barcelona
Website: http://www.oriolamat.com
Dr. Oriol Amat was President of the European Case Committee (Brussels) from 1988 to 1992; he has been a member of the Board of the College of Economists of Catalunya since 1995 and of the Management Accounting Commission of the Spanish Association for Accounting and Administration since 1994.
At present, Dr. Amat is a member of the Editorial Committees of the Journals Barcelona Management Review, Harvard Deusto, and Finanzas & Contabilidad, and he is a reviewer for Revista Española de Financiación y Contabilidad, European Accounting Review, Barcelona Management Review, European Management Journal, Información Comercial Espaañola and The International Journal of Accounting.
Philip C. Berman, Ph.D.
Former Director, European Healthcare Management Association
Dr. Philip Berman is the immediate past Director of European Healthcare Management Association (EHMA). Dr. Berman led the EHMA from 1980-2006.
Dr. Berman has considerable experience of health care systems in Western, Central and Eastern Europe. He has acted both as a World Bank and WHO consultant, advising healthcare management strategies in Poland, Hungary, Romania and Turkey.
Antonio Cabrales, Ph.D.
- Professor, Department of Economics, Universidad Carlos III de Madrid
Location: Department of Economics, Universidad Carlos III de Madrid, Madrid 126, 28903 Getafe, SPAIN
Website: http://www.eco.uc3m.es/acabrales/
Jose Manuel Freire, M.D., M.P.H., M.H.S.A.
- Chairman, Department of International Health, Escuela Nacional de Sanidad (National School of Public Health); Instituto de Salud Carlos III
Beatriz González, Ph.D.
- Professor, Applied Economics, Department of Quantitative Methods, University of Las Palmas de Gran Canaria
Location: Universidad de Las Palmas de GC, Departamento de Métodos Cuantitativos en Economía y Gestión, Campus de Tafira, 35017 Las Palmas de GC
Website: http://www.ulpgc.es/index
Dr. Beatriz González is the former President of the Spanish Health Economics Association. Among many topics she has become an expert on health professionals demographics in Europe, in pharmaceuticals policy and health technology.
Dr. González has been consultant for the WHO, OECD and other international organizations as well as the Spanish Ministry of Health. She has been involved in projects in several developing countries such as Mozambique and Brazil.
Peter Littlejohns, M.D.
- Clinical and Public Health Director, National Institute for Health and Clinical Excellence (NICE)
Professor Peter Littlejohns was formerly Professor of Public Health at St Georges Hospital Medical School and Director of the Health Care Evaluation Unit. As the Clinical Director of NICE, he is one of 4 Executive Directors and has been in post since the Institute was created in 1999. He has contributed to the establishment of all the guidance development programmes and currently has lead responsibility for Research and Development.
His research interests include most aspects of improving the cost-effectiveness of health care and he was the instigating chief scientist on a European Union BIOMED II funded project to create a critical appraisal instrument for clinical guidelines. His unit was the coordinating centre of a 12 country collaboration which developed the AGREE instrument (Appraising Guidelines, REsearch & Evaluation). He was a founding member and trustee of the AGREE Research Trust. In 1998 he spent a year in South Africa undertaking research into Health Policy funded by the Health Systems Research Trust.
Gillian Morgan, DBE, DSc (Hon), DRCOG, M.D. B.S.
Permanent Secretary of the Welsh Assembly Government, Cardiff, Wales
Previously, Dr. Morgan was Chief Executive, National Health Service Confederation and England chairman from 1996-1997 and president from 1997-1998 of the National Council for the Institute of Health Services Management.
Carles Murillo-Fort, Ph.D.
Professor of Quantitative Economics, Department of Health Sciences, Pompeu Fabra University
Ivan Planas, MSc
Researcher, Center for Health and Economics, Lecturer, Pompeu Fabra University
José Luís Pinto Prades, M.Sc., Ph.D.
Senior Lecturer in Health Economics and Applied Political Economics, Universitat Pompeu Fabra and Universidad Pablo de Olavide
Octavi Quintana, M.D.
Director for Health Research for the European Union
Dr. Quintana is responsible for the 6th Framework Programme for research and technological development. He has served in several positions in the Spanish Health Administration and as president of the European group on Ethics in Science and Technology.
Ana Rico, M.A., M.Sc., Ph.D.
- Associate Professor of Health Politics, Institute of Health Management and Health Economics, University of Oslo, Norway
- Associate Professor of Political Science and Health Policy, Institute of Health Politics and Management, Erasmus University, The Netherlands
Dr. Ana Rico has worked in various positions in educational and research institutions. To mention a few: in the period 1995-1997 she worked as an associate professor of Economics of Organizations, Department of Business Economics, Carlos III University of Madrid. In the period 1999 to 2003 Rico worked as Senior Research Fellow at the European Observatory on Health Care Systems, World Health Organization in Madrid.
Dr. Rico is an expert on consumer surveys.
Xavier Sala-i-Martin, Ph.D.
Professor of Economics, Universitat Pompeu Fabra & Columbia University
Elly Stolk, M.Sc., Ph.D.
- Senior Researcher, institute for Medical Technology Assessment (iMTA), Erasmus University Medical Center, The Netherlands
Location: Institute for Medical Technology Assessment, Erasmus University Rotterdam, PO Box 1738, Rotterdam, 3000 DR Rotterdam, The Netherlands
Website: http://www.bmg.eur.nl/personal/stolk/
After Dr. Elly Stolk conducted applied cost-effectiveness research for several years, she developed a particular interest in the measurement of individual and social preferences that can be used for informing health care decision-making. This includes both preferences for the quality of life in different health states and preferences regarding equity (fairness) in the distribution of health.
Topics of her recent studies have included equity in health, quality of life measurement, pharmaceutical reimbursement, and the consequences of Alzheimer disease. Dr. Stolk employs empirical methods ranging from questionnaires and trade-off exercises to focus groups and interviews, and draws on theory from economics as well as other social sciences.
Jeffrey L. Sturchio, Ph.D.
Vice President, External Affairs, Human Health, Europe, Middle East and Africa, Merck & Co.
Dr. Sturchio is responsible for the development, coordination, and implementation of a range of health policy and communications initiatives for the region. He is also a member of the private sector delegation to the Board of the Global Fund to Fight AIDS, TB and Malaria.
Gail Wilensky, Ph.D.
- John M. Olin Senior Fellow, Project HOPE
- Co-chair, President's Task Force to Improve Health Care Delivery for Our Nation's Veterans
Peter Zweifel, Ph.D.
Professor, Socioeconomic Institute of the University of Zurich
Dr. Zweifel is a prominent expert on health insurance.